All stock lists
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$2.22-$0.06 (-2.63%)
Market cap
$96.1M
Insider Score
Health Score
Analyst consensus
Listed since
Dec 4, 2017
Website
Insider Score
––Not scored
NRXP Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
NRXP Stock Insider Trading Activity
NRXP stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Filters
| Form 4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Javitt Jonathan C Chairman and Chief Scientist | Buy | 40,000 | $1.17 | $46.80K | New | 84,634 | Dec 17, 2024 | — | Form 4 |
| Hurvitz Chaim Director | Buy | 70,000 | $0.29 | $20.13K | New | 570,000 | Aug 30, 2023 | — | Form 4 |
| Gorovitz Aaron Director | Buy | 35,000 | $0.32 | $11.20K | New | 105,000 | Aug 30, 2023 | — | Form 4 |
| Javitt Jonathan C Chief Scientist | Buy | 100,000 | $0.33 | $33.00K | New | 446,332 | Aug 23, 2023 | — | Form 4 |
| Javitt Jonathan C Chief Scientist | Buy | 200,000 | $0.32 | $64.40K | New | 346,332 | Aug 22, 2023 | — | Form 4 |
| Willard Stephen H CHIEF EXECUTIVE OFFICER | Buy | 50,000 | $1.17 | $58.50K | New | 50,000 | Dec 16, 2022 | — | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.